BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
57 hedge funds and large institutions have $21.4M invested in BRAINSTORM CELL THERAPUTC in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 24
67% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 27
Holders
57
Holding in Top 10
–
Calls
$4.23M
Puts
$4.43M
Top Buyers
| 1 | +$1.41M | |
| 2 | +$529K | |
| 3 | +$472K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$404K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$331K |
Top Sellers
| 1 | -$5.62M | |
| 2 | -$1.63M | |
| 3 | -$1.09M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$948K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$809K |